Dr. Edward M. Kaye sold Cytokinetics Inc. ($CYTK) shares on the open market six times in the past year for a total of $3.4 million, with his most recent sale on December 1, 2025; these rank 2,472nd among insiders by value. He also sold Stoke Therapeutics Inc. ($STOK) shares 20 times for $4.4 million, most recently on December 8, 2025, ranking 2,114th. Among 11,678 insiders with sales, the average is $8.6 million over 6.4 transactions. Dr. Kaye made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 15, 2026 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | M | Common Stock | 35500 | $0.00 | 84,624.0000 | 60,397,681 | 72.27% | 0.06% |
| March 15, 2026 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | M | Restricted Stock Units | 35500 | $0.00 | 35,500.0000 | 60,397,681 | 50.00% | 0.06% |
| March 15, 2026 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | M | Restricted Stock Units | 26250 | $0.00 | 52,500.0000 | 60,397,681 | 33.33% | 0.04% |
| March 15, 2026 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | M | Common Stock | 26250 | $0.00 | 110,874.0000 | 60,397,681 | 31.02% | 0.04% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Kaye Edward M. MD | Not found | D | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Kaye Edward M. MD | Not found | D | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Kaye Edward M. MD | Not found | D | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Kaye Edward M. MD | Not found | D | Stock Option (Right to Buy) | 10034 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Kaye Edward M. MD | Not found | D | Stock Option (Right to Buy) | 13489 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Kaye Edward M. MD | Not found | D | Stock Option (Right to Buy) | 9534 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Kaye Edward M. MD | Not found | D | Stock Option (Right to Buy) | 11323 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Kaye Edward M. MD | Not found | D | Common Stock | 6692 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.00% |
| Jan. 15, 2026 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Common Stock | 197 | $63.44 | 10,174.0000 | 122,264,929 | 1.97% | 0.00% |
| Dec. 8, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 1331 | $33.10 | 49,124.0000 | 60,397,681 | 2.64% | 0.00% |
| Dec. 8, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 3825 | $31.44 | 58,729.0000 | 60,397,681 | 6.11% | 0.01% |
| Dec. 8, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 8274 | $32.52 | 50,455.0000 | 60,397,681 | 14.09% | 0.01% |
| Dec. 5, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 6367 | $31.33 | 64,735.0000 | 60,397,681 | 8.95% | 0.01% |
| Dec. 3, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | M | Common Stock | 26250 | $0.00 | 77,555.0000 | 60,397,681 | 51.16% | 0.04% |
| Dec. 4, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 5222 | $30.76 | 72,333.0000 | 60,397,681 | 6.73% | 0.01% |
| Dec. 3, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | M | Performance Stock Units | 26250 | $0.00 | 0.0000 | 60,397,681 | 100.00% | 0.04% |
| Dec. 5, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 500 | $31.85 | 62,554.0000 | 60,397,681 | 0.79% | 0.00% |
| Dec. 4, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 1231 | $31.32 | 71,102.0000 | 60,397,681 | 1.70% | 0.00% |
| Dec. 5, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 1681 | $31.15 | 63,054.0000 | 60,397,681 | 2.60% | 0.00% |
| Dec. 2, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 405 | $30.14 | 52,375.0000 | 60,397,681 | 0.77% | 0.00% |
| Dec. 2, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 661 | $29.56 | 52,780.0000 | 60,397,681 | 1.24% | 0.00% |
| Dec. 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | M | Common Stock | 4317 | $0.00 | 53,441.0000 | 56,341,074 | 8.79% | 0.01% |
| Dec. 1, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | M | Restricted Stock Units | 4317 | $0.00 | 0.0000 | 60,397,681 | 100.00% | 0.01% |
| Dec. 3, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 651 | $30.85 | 51,305.0000 | 60,397,681 | 1.25% | 0.00% |
| Dec. 3, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 419 | $30.34 | 51,956.0000 | 60,397,681 | 0.80% | 0.00% |
| Dec. 1, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | M | Non-Qualified Stock Option (Right to Buy) | 8064 | $0.00 | 0.0000 | 122,264,929 | 100.00% | 0.01% |
| Dec. 1, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | M | Common Stock | 20000 | $14.25 | 38,041.0000 | 122,264,929 | 110.86% | 0.02% |
| Dec. 1, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | M | Common Stock | 8064 | $12.40 | 18,041.0000 | 122,264,929 | 80.83% | 0.01% |
| Dec. 1, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | S | Common Stock | 28064 | $66.72 | 9,977.0000 | 122,264,929 | 73.77% | 0.02% |
| Dec. 1, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | M | Non-Qualified Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 122,264,929 | 100.00% | 0.02% |
| Nov. 11, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | M | Non-Qualified Stock Option (Right to Buy) | 5175 | $0.00 | 0.0000 | 122,264,929 | 100.00% | 0.00% |
| Nov. 11, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | M | Common Stock | 5175 | $9.66 | 15,152.0000 | 122,264,929 | 51.87% | 0.00% |
| Nov. 11, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | S | Common Stock | 5175 | $65.08 | 9,977.0000 | 122,264,929 | 34.15% | 0.00% |
| Oct. 15, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Common Stock | 199 | $62.80 | 9,977.0000 | 118,410,689 | 2.04% | 0.00% |
| Oct. 8, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | M | Common Stock | 25000 | $0.60 | 74,124.0000 | 60,397,681 | 50.89% | 0.04% |
| Oct. 8, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | M | Stock Option (Right to Buy) | 25000 | $0.00 | 542,801.0000 | 60,397,681 | 4.40% | 0.04% |
| Oct. 8, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 25000 | $30.00 | 49,124.0000 | 60,397,681 | 33.73% | 0.04% |
| Oct. 3, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 42461 | $25.09 | 49,124.0000 | 60,397,681 | 46.36% | 0.07% |
| Oct. 6, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | S | Common Stock | 6757 | $60.00 | 9,778.0000 | 118,410,689 | 40.86% | 0.01% |
| Sept. 30, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | S | Common Stock | 6695 | $55.08 | 16,535.0000 | 118,410,689 | 28.82% | 0.01% |
| Sept. 4, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | D | Restricted Stock Units | 144000 | $0.00 | 0.0000 | 54,008,883 | 100.00% | 0.27% |
| Sept. 4, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | D | Employee Stock Option (Right to Buy) | 178500 | $0.00 | 37,500.0000 | 54,008,883 | 82.64% | 0.33% |
| Sept. 2, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 14860 | $20.14 | 137,581.0000 | 54,008,883 | 9.75% | 0.03% |
| Aug. 29, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 1029 | $20.00 | 152,441.0000 | 54,008,883 | 0.67% | 0.00% |
| Sept. 3, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 45996 | $20.13 | 91,585.0000 | 54,008,883 | 33.43% | 0.09% |
| Sept. 2, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | S | Common Stock | 6756 | $50.00 | 23,230.0000 | 118,410,689 | 22.53% | 0.01% |
| Aug. 18, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 12126 | $18.24 | 153,470.0000 | 54,008,883 | 7.32% | 0.02% |
| Aug. 14, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | M | Performance Stock Units | 26250 | $0.00 | 26,250.0000 | 54,008,883 | 50.00% | 0.05% |
| Aug. 14, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | M | Common Stock | 26250 | $0.00 | 165,596.0000 | 54,008,883 | 18.84% | 0.05% |
| Aug. 14, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | A | Performance Stock Units | 52500 | $0.00 | 52,500.0000 | 54,008,883 | 9999.99% | 0.10% |
| July 15, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Common Stock | 328 | $38.01 | 29,986.0000 | 118,410,689 | 1.11% | 0.00% |
| June 10, 2025 | Avidity Biosciences, Inc. | $RNAM | Kaye Edward M. MD | Director | A | Stock Option (Right to Buy) | 10034 | $0.00 | 10,034.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 10, 2025 | Avidity Biosciences, Inc. | $RNAM | Kaye Edward M. MD | Director | A | Common Stock | 6692 | $0.00 | 6,692.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 5, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | S | Common Stock | 3636 | $32.10 | 29,658.0000 | 118,410,689 | 10.92% | 0.00% |
| May 14, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Common Stock | 7333 | $0.00 | 33,294.0000 | 118,410,689 | 28.25% | 0.01% |
| May 14, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Non-Qualified Stock Option (Right to Buy) | 10880 | $0.00 | 10,880.0000 | 118,410,689 | 9999.99% | 0.01% |
| April 15, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Common Stock | 324 | $38.56 | 25,961.0000 | 118,410,689 | 1.26% | 0.00% |
| March 20, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | A | Employee Stock Option (Right to Buy) | 216000 | $0.00 | 216,000.0000 | 54,008,883 | 9999.99% | 0.40% |
| March 19, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 8907 | $8.27 | 139,346.0000 | 54,008,883 | 6.01% | 0.02% |
| March 18, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | S | Common Stock | 10382 | $8.67 | 148,253.0000 | 54,008,883 | 6.54% | 0.02% |
| March 20, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | Not found | A | Restricted Stock Units | 144000 | $0.00 | 144,000.0000 | 54,008,883 | 9999.99% | 0.27% |
| March 15, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | M | Restricted Stock Units | 35500 | $0.00 | 71,000.0000 | 54,008,883 | 33.33% | 0.07% |
| March 15, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | M | Common Stock | 26250 | $0.00 | 158,635.0000 | 54,008,883 | 19.83% | 0.05% |
| March 15, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | M | Common Stock | 35500 | $0.00 | 132,385.0000 | 54,008,883 | 36.64% | 0.07% |
| March 15, 2025 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | M | Restricted Stock Units | 26250 | $0.00 | 78,750.0000 | 54,008,883 | 25.00% | 0.05% |
| Jan. 2, 2025 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Common Stock | 255 | $48.93 | 25,637.0000 | 0 | 1.00% | 0.00% |
| Dec. 30, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | M | Common Stock | 35000 | $0.60 | 96,885.0000 | 56,341,074 | 56.56% | 0.06% |
| Dec. 30, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | M | Employee Stock Option (Right to Buy) | 35000 | $0.00 | 567,801.0000 | 56,341,074 | 5.81% | 0.06% |
| Dec. 9, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | S | Common Stock | 6786 | $12.99 | 61,885.0000 | 56,341,074 | 9.88% | 0.01% |
| Dec. 6, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | S | Common Stock | 6170 | $12.78 | 68,671.0000 | 56,341,074 | 8.24% | 0.01% |
| Dec. 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | M | Common Stock | 26250 | $0.00 | 74,841.0000 | 56,341,074 | 54.02% | 0.05% |
| Dec. 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | A | Performance Stock Units | 52500 | $0.00 | 52,500.0000 | 56,341,074 | 9999.99% | 0.09% |
| Dec. 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | M | Performance Stock Units | 26250 | $0.00 | 26,250.0000 | 56,341,074 | 50.00% | 0.05% |
| Dec. 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | M | Performance Stock Units | 26500 | $0.00 | 26,500.0000 | 56,341,074 | 50.00% | 0.05% |
| Dec. 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | M | Common Stock | 26500 | $0.00 | 75,091.0000 | 56,341,074 | 54.54% | 0.05% |
| Dec. 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | A | Performance Stock Units | 53000 | $0.00 | 53,000.0000 | 56,341,074 | 9999.99% | 0.09% |
| Dec. 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | M | Common Stock | 21591 | $0.00 | 48,591.0000 | 56,341,074 | 79.97% | 0.04% |
| Dec. 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | M | Restricted Stock Unit (RSU) | 21591 | $0.00 | 4,317.0000 | 56,341,074 | 83.34% | 0.04% |
| Oct. 1, 2024 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Common Stock | 237 | $52.60 | 25,382.0000 | 0 | 0.94% | 0.00% |
| July 1, 2024 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Common Stock | 228 | $0.00 | 25,145.0000 | 0 | 0.92% | 0.00% |
| June 13, 2024 | Avidity Biosciences, Inc. | $RNAM | Kaye Edward M. MD | Director | A | Stock Option (Right to Buy) | 13489 | $0.00 | 13,489.0000 | 0 | 9999.99% | 0.00% |
| March 27, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | A | Employee Stock Option (Right to Buy) | 159000 | $0.00 | 159,000.0000 | 43,994,862 | 9999.99% | 0.36% |
| March 27, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | A | Restricted Stock Units | 105000 | $0.00 | 105,000.0000 | 43,994,862 | 9999.99% | 0.24% |
| May 20, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | S | Common Stock | 2664 | $16.05 | 27,000.0000 | 43,994,862 | 8.98% | 0.01% |
| May 20, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | S | Common Stock | 39686 | $15.39 | 29,664.0000 | 43,994,862 | 57.23% | 0.09% |
| May 15, 2024 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Non-Qualified Stock Option (Right to Buy) | 3636 | $0.00 | 3,636.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Common Stock | 5600 | $0.00 | 24,917.0000 | 0 | 28.99% | 0.00% |
| March 15, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | M | Common Stock | 35500 | $0.00 | 80,500.0000 | 43,994,862 | 78.89% | 0.08% |
| March 15, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | M | Restricted Stock Units | 35500 | $0.00 | 106,500.0000 | 43,994,862 | 25.00% | 0.08% |
| March 19, 2024 | Stoke Therapeutics, Inc. | $STOK | Kaye Edward M. MD | CEO | S | Common Stock | 11150 | $6.10 | 69,350.0000 | 43,994,862 | 13.85% | 0.03% |
| Jan. 2, 2024 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Common Stock | 148 | $84.12 | 19,317.0000 | 0 | 0.77% | 0.00% |
| Oct. 2, 2023 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Common Stock | 448 | $27.88 | 19,169.0000 | 0 | 2.39% | 0.00% |
| July 3, 2023 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Common Stock | 374 | $33.36 | 18,721.0000 | 0 | 2.04% | 0.00% |
| June 15, 2023 | Avidity Biosciences, Inc. | $RNAM | Kaye Edward M. MD | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2023 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Common Stock | 5000 | $0.00 | 18,347.0000 | 0 | 37.46% | 0.00% |
| May 10, 2023 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| April 3, 2023 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Common Stock | 298 | $37.71 | 13,347.0000 | 0 | 2.28% | 0.00% |
| Jan. 3, 2023 | CYTOKINETICS INC | $CYTK | Kaye Edward M. MD | Director | A | Common Stock | 253 | $44.35 | 13,049.0000 | 0 | 1.98% | 0.00% |